fbpx

HR News, Human Resources

BREAKING NEWS: CDC Issues New Quarantine Guidance Post Vaccine

Hey Compliance Warriors!

The CDC has issued some new guidance regarding vaccinations and individuals who get vaccinated. These updates will affect your workplace. Read on…

Summary of recent changes (last updated February 10, 2021):
  • New recommendations for preventing, reporting, and managing mRNA COVID-19 vaccine administration errors (Appendix A).
  • Clarification on contraindications and precautions. Persons with a known (diagnosed) allergy to PEG, another mRNA vaccine component, or polysorbate, have a contraindication to vaccination. Persons with a reaction to a vaccine or injectable therapy that contains multiple components, one of which is PEG, another mRNA vaccine component or polysorbate, but in whom it is unknown which component elicited the immediate allergic reaction have a precaution to vaccination.
  • Updated information on delayed, local injection-site reactions after the first mRNA vaccine dose. These reactions are neither a contraindication or precaution to the second dose.
  • Updated quarantine recommendations for vaccinated persons. Fully vaccinated persons who meet the criteria will no longer be required to quarantine following an exposure to someone with COVID-19. Additional considerations for patients and residents in healthcare settings are provided.
  • Additional information and updated recommendations for testing for TB infection. TB testing can be done before or at the same time as mRNA COVID-19 vaccination, or otherwise delayed for ≥4 weeks after the completion of mRNA COVID-19 vaccination.

https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html


 

Be Audit-Secure™

Lisa Smith, SPHR, SHRM-SCP


About LISA SMITH, SPHR, SHRM-SCP

Lisa Smith is CEO of Andere Corporation and Chief Content Developer at HelpDeskSuites.com. Follow her on Twitter, connect with her on LinkedIn, listen to her Small Business Spoonfuls Podcast, and find more in her Compliance Warriors Facebook Group.

Log in or Register to save this content for later.
Tags: